List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 60 studies with search of:   "Measles"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Prophylactic Antibiotics in Measles
Conditions: Post-Measles Pneumonia;   Measles
Intervention: Drug: Sulfamethoxazole-Trimethoprim
2 Completed Impact of HIV on Measles and Measles Immunisation
Conditions: HIV Infection;   Measles;   Children
Intervention: Biological: standard-titer measles vaccine
3 Completed Long-Term Follow-up of Measles Antibodies
Condition: Measles
Intervention: Biological: Measles vaccine
4 Completed A Measles, Mumps, and Rubella Investigational Vaccine Trial
Condition: Measles
Interventions: Biological: V205C, measles, mumps, and rubella virus vaccine live;   Biological: Comparator: Measles, Mumps, and Rubella Virus Vaccine Live
5 Active, not recruiting Early Two-Dose Measles Vaccination Trial
Condition: Measles
Intervention: Biological: Measles vaccine
6 Active, not recruiting A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
Conditions: HIV Infections;   Measles
Interventions: Biological: Attenuvax;   Biological: M-M-R-II
7 Completed Non-Specific Effects of Standard Titre Measles Vaccination
Condition: Measles
Intervention: Biological: Measles and inactivated polio vaccine
8 Recruiting Vaccine-Induced Measles Immunity in Infants
Condition: Measles
Interventions: Biological: Attenuvax;   Biological: MMR-II
9 Recruiting Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine 208136
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: VarilrixTM;   Biological: PriorixTM;   Biological: GSK Biologicals' vaccine 208136
10 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
11 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
12 Completed Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Intervention: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
13 Completed Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MeMuRu-OKA (study vacc);   Biological: MMR, Varicella vacc (control)
14 Completed Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MeMuRu-OKA (study vac);   Biological: MMR, Varicella vacc (control)
15 Completed Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks
16 Active, not recruiting Evaluate Vaccine Agst Chickenpox & a Comb Vaccine Agst 4 Viral Childhood Diseases: Measles, Mumps, Rubella & Chickenpox.
Conditions: Measles;   Mumps;   Rubella;   Chickenpox
Interventions: Biological: Priorix-tetra™;   Biological: Priorix™;   Biological: Varilrix™
17 Recruiting Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Hepatitis A
Interventions: Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella;   Biological: Attenuated Measles Mumps Rubella; Inactivated Hep A vaccine;   Biological: Inactivated Hep A vaccine; Attenuated Measles Mumps Rubella
18 Completed Long-Term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMRV;   Biological: MMR (Priorix®);   Biological: Varicella (Varilrix®)
19 Completed Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
Conditions: Measles;   Mumps;   Rubella
Intervention: Biological: MMR vaccine (Priorix)
20 Completed ProQuad® rHA Safety
Conditions: Measles;   Mumps;   Rubella;   Varicella
Intervention: Biological: ProQuad® manufactured with rHA

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services